partially funded by Italian Ministry of Health—Ricerca Corrente(no grant number).
Objectives:Treatment of metastatic colorectal cancer(mCRC)includes resection of liver metastases(LM),however,no validated biomarker identifies patients most likely to benefit from this procedure.This meta-analysis aim...
BACKGROUND The prognosis for oesophageal carcinoma is poor,but once distant metastases emerge the prognosis is considered hopeless.There is no consistent protocol for the early identification and aggressive management...
supported by grants through funding from the Ministry of Science and Technology(MOST 109-2314-B-037-046-MY3,MOST110-2314-B-037-097,MOST 111-2314-B-037-070-MY3,MOST 111-2314-B-037-049);the Ministry of Health and Welfare(MOHW111-TDU-B-221-114014);funded by the Health and Welfare Surcharge of on Tobacco Products,and the Kaohsiung Medical University Hospital(KMUH110-0R37,KMUH110-0R38,KMUH110-0M34,KMUH110-0M35,KMUH110-0M36,KMUH-DK(B)110004-3);KMU Center for Cancer Research(KMU-TC111A04-1);KMU Office for Industry-Academic Collaboration(S109036),Kaohsiung Medical University.
The controversial outcomes in patients with metastatic colorectal cancer(mCRC)highlight the need for developing effective systemic neoadjuvant treatment strategies to improve clinical results.The optimal treatment cyc...
BACKGROUND Peritoneal metastasis from colorectal cancer(CRC)carries a poor prognosis in most studies.The majority of those studies used either a single-agent or doublet chemotherapy regimen in the first-line setting.A...
National Natural Science Foundation of China,No.81902385;Medical Research Projects of Jiangsu Province,No.Y2018094 and No.H2018056;and Science and Technology Project of Jiangsu Province,No.BK20201173。
BACKGROUND Metachronous pulmonary and pancreatic metastases from colorectal cancer are rare.The diagnosis of pancreatic metastases is difficult and predominantly relies on computed tomography,pathology and immunohisto...
BACKGROUND Gastrointestinal stromal tumor(GIST)usually originates in the stomach,followed by the small intestine,rectum,and other parts of the gastrointestinal tract.The most common sites of metastasis are the liver a...
Metastasectomy was initially described in the 1970s as a therapeutic strategy for patients with metastatic renal cell carcinoma.Since that time,systemic therapy options have grown exponentially,most recently with the ...
It is estimated that approximately 80%-90%of pancreatic ductal adenocarcinoma(PDAC)will present with unresectable disease with about half of patients presenting with distant metastases.The prognosis of these patients ...
a grant from the National Natural Science Foundation of China(No.81702964).
The clear cell renal cell carcinoma(ccRCC)appears to have a predilection for metastasizing to the pancreas/11 In the recent years,there are increasing numbers of clinical series from Europe and the United States that ...
Oligometastatic non-small cell lung cancer(NSCLC)describes an intermediate stage of NSCLC between localized and widely-disseminated disease.This stage of NSCLC is characterized by a limited number of metastases and a ...